Title of article
A Narrative Review on Evaluation of Hypercoagulability State in Severe Covid-19 Patients with Background Risk Factors
Author/Authors
Moghimi, Minoosh Dept. of of Hematology-Medical Oncology - Vali-e-Asr Hospital - School of Medicine - Zanjan University of Medical Sciences, Zanjan , Khodadadi, Kasra Dept. of Internal Medicine - Vali-e-Asr Hospital - School of Medicine - Zanjan University of Medical Sciences, Zanjan , Mortazavi, Yousef Cancer Gene Therapy Research Center - Zanjan University of Medical Sciences, Zanjan
Pages
8
From page
296
To page
303
Abstract
Coronavirus disease (COVID-19) can induce coagulopathy at the base of sepsis-induced coagulopathy (SIC), which is an important cause of death in these patients. Cytokine storm causes imbalance in coagulation and fibrinolytic system. A combination of hypercoagulability state, decrease or inhibition of fibrinolysis and endotheliopathy causes thromboembolic events. Underlying diseases such as diabetes and hypertension with a high rate of mortality in COVID-19 and some conditions like aging and obesity are the main disorders with hemostatic disturbance and increase of coagulopathy. Therefore, it seems that the combination of COVID-19 infection and these risk factors increase the risk of thromboembolic complications all together.
Keywords
COVID-19 , DIC , Coagulopathy , SarsCovid , Blood coagulation disorder
Journal title
Journal of Advances in Medical and Biomedical Research
Serial Year
2020
Record number
2519328
Link To Document